Skip to main content
OpenTrials
Completed

NCT Number: NCT01396343

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

The purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or environmental exposures or a combination of both put children and adolescents at risk for getting MS.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–21 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham, Birmingham, Alabama, United States

Loading trial locations.

About this study

The overall goal of this project is to determine whether well-established environmental and genetic risk factors for adult onset MS play an important role in susceptibility to pediatric-onset MS. Our study design is based on the hypothesis that genetic influences, specifically variation at HLA-DRB1 and other confirmed non-MHC MS loci, as well as environmental exposures including EBV infection and tobacco smoke, contribute to disease risk. In addition, we will also examine the relationship between serum levels of 25(OH) vitamin D3 and prior vitamin D status, and risk for pediatric onset MS. Finally, we will investigate whether specific G x E, and other multivariable relationships influencing risk exist for pediatric-onset MS. There are 16 collaborating sites other than UCSF that will enroll cases and controls for this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Children are eligible for this study as cases if:

  • They have MS or clinically isolated syndrome (CIS):
  • MS: As defined by the 2010 McDonald criteria for diagnosis of MS (Polman 2010),
  • CIS: A first demyelinating event indicating high risk for MS (i.e., one clinical event involving the spinal cord, the optic nerve, the brainstem or cerebellum, or occasionally the hemispheres) and at least 2 silent T2 bright areas on a brain or spinal cord MRI (at least one must be in the brain); AND
  • They are three years of age or older; AND
  • Disease onset occurred before 18 years of age.

Patients are not eligible for study participation if:

  • Disease onset occurred more than 4 years prior to the opportunity to enroll; OR
  • They have had an organ transplant; OR
  • They are known to have neuromyelitis optica (NMO).

Children are not eligible to participate as pediatric controls if:

  • They are two years of age or younger; OR
  • They are 22 years of age or older; OR
  • They are known to have MS or another demyelinating disease (for example, neuromyelitis optica or acute disseminated encephalomyelitis); OR
  • They have a biological family member who has been enrolled as a control; OR
  • They have an immediate, biological family member (parent/sibling) who has been diagnosed with MS; OR
  • They have an autoimmune disorder (except asthma or eczema); OR
  • They have had an organ transplant; OR
  • They have a chronic neurological condition with major disability (this does not include, for example, migraine, controlled seizures, and mild learning disabilities such as ADD or ADHD).

Treatment and study plan

Primary outcomes

  1. Identify risk factors and their respective contribution to developing pediatric multiple sclerosis

    Time frame: 4 year data collection, 1 year analysis

    The primary objective of this study is to determine if risk factors identified for adult MS such as HLA-DRB1*1501/1503, EBV, 25(OH) vitamin D3 insufficiency, and exposure to cigarette smoking are also risk factors for pediatric MS, and if there are interactions between them analyzing data collected from questionnaires for environmental exposure, demographic and food frequency as well as sample blood specimens.

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago
  • Baylor College of Medicine
  • Boston Children's Hospital
  • Children's Hospital Colorado
  • Children's Hospital of Philadelphia
  • Children's National Research Institute
  • Loma Linda University
  • Massachusetts General Hospital
  • Mayo Clinic
  • New York University
  • Primary Children's Hospital
  • State University of New York at Buffalo
  • The Cleveland Clinic
  • University of Alabama at Birmingham
  • University of Texas
  • Washington University School of Medicine

Registry information

Important dates

Study start
2011
Primary completion
2018
Study completion
2018
First posted
Jul 18, 2011
Registry last updated
Oct 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.